Hypermobility Syndrome, AKA Joint Hypermobility Syndrome (JHS), Ehlers-Danlos Syndrome Hypermobility Type (EDS-HT), Hypermobility Spectrum Disorders (HSD)

July 18, 2015

Indian Articles: Benign Joint Hypermobility Syndrome – not so ‘Benign’

This is a recent and interesting Indian case report by rheumatologists at the P.D. Hinduja Hospital and Research Centre, Mumbai.

Indian Articles: Benign Joint Hypermobility Syndrome – not so ‘Benign’

Yathish GC, Canchi Balakrishnan, Mangat Gurmeet, Taral Parikh, Sagdeo Parikshit, Girish Kakade

Internet Journal of Rheumatology and Clinical Immunology 3.1 (2015)


The article reports the case of a 53-year-old lady whom the authors finally diagnosed with Joint Hypermobility Syndrome. The lady presented with a 16-year history of instability while walking, repeated knee injuries, and buckling and give away sensation at both knee joints. She had history of an elbow dislocation (traumatic) and had complaints of multiple joint and soft tissue pain while performing household activities. In extra-articular symptoms, she had been diagnosed with irritable bowel syndrome.

The corresponding author, Dr. Yatish, is a resident in Rheumatology. I had the opportunity to communicate with him and was enthused by his interest in hypermobility syndrome. Dr. Yatish wrote about how H-EDS/JHS was responsible for such a considerable morbidity in the patient and how underdiagnosed this condition is in India.

I hope that with more Indian rheumatologists getting interested in this condition, it is a matter of time when we will be able to develop customized treatment protocols and physical therapy regimes that are suited to Indian patients and the Indian health care infrastructure.

I also think that the millions of undiagnosed patients in India are important as a large pool of  unaddressed disease morbidity, the identification and treatment of which can benefit the community health as a whole. That should be of interest to the patients living in pain and to the health ministries and health departments of the nation.

What should be of great interest to medical researchers in the fields of Rheumatology, Orthopedics, Physical and Rehabilitation Medicine, Gastroenterology, Clinical Genetics and Public Health Medicine among others is that these millions of patients can lead to new insights, new studies (and scores of new articles if that is what matters in the end), and new knowledge.

The recent and revolutionary advances in medicine, physical therapy, genetics and technology enabling not just multidisciplinary but global information sharing and collaboration, have brought us to a momentous point in human history where we can identify and manage this disease that has hitherto been hiding in plain sight.